Back to Agenda
Advancing Alzheimer's Innovation: Patient Advocacy, Caregiver Support and Health Care System Impact
Session Chair(s)
Robert Feeney, MBA
Head, North America Public Policy Services
Sanofi, United States
As researchers work towards disease modifying therapies, we must also press ahead on initiatives that prepare society for the proper care of Alzheimer’s sufferers — and caregivers. A small number of nations — France, the United Kingdom and Australia among them — have created comprehensive national policies to manage Alzheimer’s disease and to offer compassionate care to its sufferers. Employers are also being impacted by loss of productivity and responding by increasing their support for employees who are providing care to loved ones with Alzheimer’s and other age-related chronic conditions. Private sector innovation is also starting to respond to the growing need to help individuals remain independent for as long as possible. This forum will focus on best practices in care delivery to support patients and caregivers, whether in institutions or at home.
Learning Objective : Describe opportunities to bridge the regulatory and industry gap; Identify how industry and other stakeholders increase faster clinical trial enrollment and enhance data collection; Discuss examples where patients/industry/regulatory collaborated, thus advancing therapies.
Speaker(s)
Panelist
Cynthia A Bens
Personalized Medicine Coalition, United States
Senior Vice President, Public Policy
Panelist
Francesca Cerreta, PharmD, MPharm, MS
European Medicines Agency, Netherlands
Principal Scientific Officer
Panelist
Drew Holzapfel, MBA
The Global CEO Initiative On Alzheimer's Disease, United States
Executive Director
Have an account?